Alex McCormick

962 total citations
17 papers, 758 citations indexed

About

Alex McCormick is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Alex McCormick has authored 17 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pharmacology and 5 papers in Molecular Biology. Recurrent topics in Alex McCormick's work include Pharmacogenetics and Drug Metabolism (6 papers), PARP inhibition in cancer therapy (4 papers) and DNA Repair Mechanisms (2 papers). Alex McCormick is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), PARP inhibition in cancer therapy (4 papers) and DNA Repair Mechanisms (2 papers). Alex McCormick collaborates with scholars based in United Kingdom, United States and Singapore. Alex McCormick's co-authors include Robert G. Davidson, Fergus McTaggart, Dennis W. Schneck, Linda K. Buckett, Geoffrey A. Holdgate, D. McKillop, P. J. Phillips, Michael G. Hutchison, Helen Swaisland and Nick Bushby and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Cardiology and Clinical Pharmacokinetics.

In The Last Decade

Alex McCormick

17 papers receiving 732 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex McCormick United Kingdom 9 290 260 227 142 94 17 758
Georgina Meneses‐Lorente United Kingdom 17 260 0.9× 340 1.3× 107 0.5× 90 0.6× 120 1.3× 51 843
S. Unger Germany 10 257 0.9× 137 0.5× 180 0.8× 184 1.3× 139 1.5× 19 724
Benny Amore United States 17 278 1.0× 258 1.0× 87 0.4× 142 1.0× 103 1.1× 33 927
Yvonne Lau United States 14 638 2.2× 493 1.9× 217 1.0× 257 1.8× 280 3.0× 30 1.3k
Katrijn Bogman Switzerland 10 317 1.1× 192 0.7× 98 0.4× 120 0.8× 132 1.4× 18 732
Shazia Ali United States 9 216 0.7× 259 1.0× 206 0.9× 35 0.2× 169 1.8× 15 756
Michael Man United States 16 343 1.2× 383 1.5× 87 0.4× 84 0.6× 93 1.0× 23 1.0k
Emiko Sugiyama Japan 15 395 1.4× 257 1.0× 109 0.5× 125 0.9× 210 2.2× 32 1.0k
Susan E. Pratt United States 15 553 1.9× 425 1.6× 106 0.5× 67 0.5× 62 0.7× 26 986

Countries citing papers authored by Alex McCormick

Since Specialization
Citations

This map shows the geographic impact of Alex McCormick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex McCormick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex McCormick more than expected).

Fields of papers citing papers by Alex McCormick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex McCormick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex McCormick. The network helps show where Alex McCormick may publish in the future.

Co-authorship network of co-authors of Alex McCormick

This figure shows the co-authorship network connecting the top 25 collaborators of Alex McCormick. A scholar is included among the top collaborators of Alex McCormick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex McCormick. Alex McCormick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Bookstaver, P. Brandon, Kevin W. Chamberlin, Alex McCormick, et al.. (2023). Postgraduate year 1 pharmacy residency equivalency—2023. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6(3). 291–296. 1 indexed citations
2.
Rapport, Daniel, et al.. (2021). Oral Valproate Sodium as an Alternative to Benzodiazepine in the Treatment of Catatonia- A Case Report. SHILAP Revista de lepidopterología. 8. 1 indexed citations
3.
Hanna, Catherine, Kathreena M. Kurian, Karin Williams, et al.. (2020). Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-Oncology. 22(12). 1840–1850. 98 indexed citations
4.
McCormick, Alex, et al.. (2020). Real-World Evaluation of Dosing in Patients Converted From Insulin Glargine (Lantus) to Insulin Glargine (Basaglar). Annals of Pharmacotherapy. 54(9). 846–851. 5 indexed citations
5.
McCormick, Alex, Helen Swaisland, Venkatesh Pilla Reddy, Maria Learoyd, & Graeme Scarfe. (2017). In vitro evaluation of the inhibition and induction potential of olaparib, a potent poly(ADP-ribose) polymerase inhibitor, on cytochrome P450. Xenobiotica. 48(6). 555–564. 26 indexed citations
6.
Tang, Weifeng, Alex McCormick, Jianguo Li, & Eric Masson. (2016). Clinical Pharmacokinetics and Pharmacodynamics of Cediranib. Clinical Pharmacokinetics. 56(7). 689–702. 22 indexed citations
7.
Chalmers, Anthony J., Alan Jackson, Helen Swaisland, et al.. (2016). DDIS-19. OLAPARIB PENETRATES TUMOUR MARGINS AS WELL AS CONTRAST ENHANCING REGIONS OF GLIOBLASTOMA AT THERAPEUTIC LEVELS: INTERIM RESULTS OF THE OPARATIC TRIAL NCT01390571. Neuro-Oncology. 18(suppl_6). vi51–vi51. 1 indexed citations
8.
McCormick, Alex & Helen Swaisland. (2016). In vitro assessment of the roles of drug transporters in the disposition and drug–drug interaction potential of olaparib. Xenobiotica. 47(10). 903–915. 42 indexed citations
9.
Hall, Michael, Kevin Brady, Iain Gardner, et al.. (2011). The Drug Metabolism Discussion Group in 2011. Xenobiotica. 41(8). 603–604. 3 indexed citations
10.
11.
McCormick, Alex, Eva M. Lenz, P. J. Phillips, et al.. (2007). In vitrometabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes. Xenobiotica. 37(9). 972–985. 4 indexed citations
12.
Lenz, Eva M., Alexander C. Jordan, Susan M. Smith, et al.. (2006). HPLC–NMR with severe column overloading: Fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126. Journal of Pharmaceutical and Biomedical Analysis. 43(3). 1065–1077. 9 indexed citations
13.
McKillop, D., et al.. (2005). Cytochrome P450-dependent metabolism of gefitinib. Xenobiotica. 35(1). 39–50. 114 indexed citations
14.
McKillop, D., Alex McCormick, P. J. Phillips, et al.. (2004). In vitrometabolism of gefitinib in human liver microsomes. Xenobiotica. 34(11-12). 983–1000. 54 indexed citations
15.
16.
McKillop, D., D J Back, Alex McCormick, James A. Evans, & J. Tjia. (1999). Preclinical andin vitroassessment of the potential of D0870, an antifungal agent, for producing clinical drug interactions. Xenobiotica. 29(4). 395–408. 5 indexed citations
17.
McKillop, D., et al.. (1993). Metabolism of Casodex in laboratory animals. Xenobiotica. 23(7). 781–798. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Georgina Meneses‐Lorente Breakdown of academic impact, for papers by S. Unger Breakdown of academic impact, for papers by Benny Amore Breakdown of academic impact, for papers by Yvonne Lau Breakdown of academic impact, for papers by Katrijn Bogman Breakdown of academic impact, for papers by Shazia Ali Breakdown of academic impact, for papers by Michael Man Breakdown of academic impact, for papers by Emiko Sugiyama Breakdown of academic impact, for papers by Susan E. Pratt
Rankless by CCL
2026